Literature DB >> 3275510

The compartment syndrome. An experimental and clinical study of muscular energy metabolism using phosphorus nuclear magnetic resonance spectroscopy.

R B Heppenstall1, A A Sapega, R Scott, D Shenton, Y S Park, J Maris, B Chance.   

Abstract

In an experimental ischemic compartment syndrome in dogs, phosphorus (31P) nuclear magnetic resonance (NMR) spectroscopy was used to determine the tissue pressure threshold at which resting skeletal muscle begins to use anaerobic energy sources due to insufficient cellular oxygen delivery. The interactive effects of systemic perfusion pressure and moderate muscle trauma on this anaerobic threshold were also evaluated. The severity of cell injury produced by various degrees of compartment pressurization over an eight-hour period was concomitantly studied using muscle biopsy and electron microscopy. Clinical correlation of a preliminary patient series studied using 31P-NMR demonstrated that the threshold for cellular metabolic derangement in skeletal muscle subjected to increased tissue pressure was more closely associated with the difference between mean arterial blood pressure (MABP) and compartment pressure than with the absolute compartment pressure alone. The difference is termed MABP-compartment pressure, or delta P. The lowest delta P at which a normal cellular metabolic state can be maintained is approximately 30 mmHg in normal muscle and 40 mmHg in moderately traumatized muscle. It is imperative to interpret compartment pressure measurements in light of the degree of soft tissue trauma sustained and the patient's blood pressure, as well as the clinical signs and symptoms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275510

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  N-acetylcysteine protects striated muscle in a model of compartment syndrome.

Authors:  Stephen R Kearns; David E O'Briain; Katherine M Sheehan; Cathal Kelly; David Bouchier-Hayes
Journal:  Clin Orthop Relat Res       Date:  2010-03-23       Impact factor: 4.176

2.  Postanesthetic brachial triceps myonecrosis in a Spanish-bred horse.

Authors:  Ignacio Ayala; M Jesús Rodríguez; Carla Aguirre; Antonio J Buendía; Eliseo Belda; Francisco G Laredo
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

3.  [Acute therapeutic measures for limb salvage Part 1 : Haemorrhage control, emergency revascularization, compartment syndrome].

Authors:  C Willy; M Stichling; M Engelhardt; D Vogt; D A Back
Journal:  Unfallchirurg       Date:  2016-05       Impact factor: 1.000

4.  Crush syndrome following unconsciousness: need for urgent orthopaedic referral.

Authors:  A D Shaw; S U Sjølin; M M McQueen
Journal:  BMJ       Date:  1994-10-01

5.  Well leg compartment syndrome after robotic prostatectomy: a word of caution.

Authors:  Shankar R Raman; Zafar Jamil
Journal:  J Robot Surg       Date:  2009-06-03

Review 6.  Common compartment syndromes in athletes. Treatment and rehabilitation.

Authors:  M R Hutchinson; M L Ireland
Journal:  Sports Med       Date:  1994-03       Impact factor: 11.136

7.  New noninvasive ultrasound technique for monitoring perfusion pressure in a porcine model of acute compartment syndrome.

Authors:  Tigran Garabekyan; Gary C Murphey; Brandon R Macias; John E Lynch; Alan R Hargens
Journal:  J Orthop Trauma       Date:  2009-03       Impact factor: 2.512

8.  The incidence of compartment syndrome after flexible nailing of pediatric tibial shaft fractures.

Authors:  Nirav K Pandya; Eric W Edmonds; Scott J Mubarak
Journal:  J Child Orthop       Date:  2011-11-01       Impact factor: 1.548

Review 9.  [Acute extremity compartment syndrome: current concepts in diagnostics and therapy].

Authors:  R M Sellei; F Hildebrand; H-C Pape
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

10.  Acute atraumatic compartment syndrome in an athlete: a case report.

Authors:  G T Stollsteimer; W R Shelton
Journal:  J Athl Train       Date:  1997-07       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.